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This is an open access article under the CCSCIENTIFIC ARTICLELong-Term Outcome of Arthroscopic Resection
Arthroplasty With or Without Interposition for
Thumb Basal Joint ArthritisTyson K. Cobb, MD,* Anna L. Walden, MS,† Ying Cao, MS‡Purpose To report results on 144 cases following arthroscopic resection arthroplasty (ARA)
with or without interposition for basal joint arthritis.
Methods Cases undergoing ARA for thumb carpometacarpal osteoarthritis between 2004 and
2011 were prospectively enrolled (n ¼ 178). Data were collected before surgery and after
surgery at 1, 3, 6, and 12 months and annually thereafter. Patients were excluded for less than
1-year follow-up or concomitant procedures that interfered with evaluation of the variable of
interest (interposition). Human acellular dermal matrix (GRAFTJACKET) was the most
commonly used interposition. Outcomes on 19 cases of interposition using collagen bioimplant
(OrthADAPT) and porous polyurethaneurea (Artelon) scaffolds were also reported. Compar-
ative analyses were performed on 52 patients with GRAFTJACKET interposition and on 73
without. Mean follow-up was 7.4 and 5.6 years with and without interposition, respectively.
Descriptive statistics were evaluated on all baseline variables. Raw change scores of grip, pinch,
and pain outcomes were evaluated. Confounding variables at a signiﬁcance level of P less than
.05 were adjusted for in linear mixed models, and an analysis of covariance was employed
through an unstructured type of variance-covariance matrix.
Results Change scores from baseline to 1 year for the interposition group for pain (numerical
rating scale, 0e10), pinch, and grip wase5.8, 3.3, and 7, respectively, ande5.1, 2.1, and 9 for
the noninterposition group. Postoperative mean satisfaction was 4.7 and 4.4 for the with- and
without-interposition groups, respectively. There were 4 failures with and 2 without interpo-
sition. Artelon and OrthADAPT did poorly with unacceptably high failure rates.
Conclusions This study suggested that interposition is not necessary following ARA for thumb
basal joint arthritis. Because arthroscopic interposition of material contributes to health care
costs in terms of patient and facility costs without clear beneﬁt to the patient, routine use of
expensive interposition products should be abandoned or carefully evaluated with a prospective
randomized controlled trial. (J Hand Surg Am. 2015;40(9):1844e1851. Copyright 2015 The
Authors. Published by Elsevier Inc. on behalf of the American Society for Surgery of the Hand.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).)
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SAL JOINT ARTHRITIS 1845A RTHROSCOPIC RESECTIONARTHROPLASTY (ARA) isan effective and well-established treatmentoption for basal joint arthritis. Nevertheless, all
series have been small. Whereas some surgeons have
chosen to use interposition,1e5 others have reported
similar results without interposition.6e8 Outcomes
with and without interposition appear comparable.9
The purpose of this study was to report the results on
144 cases followingARA for basal joint arthritis and to
compare subjective and objective outcomes to deter-
mine differences between those who received inter-
position versus those who did not.
ARA FOR THUMB BAMATERIALS AND METHODS
Procedures were in accordance with the Helsinki
Declaration of 1975 (2008 revision). All human pro-
tections for this study were institutional review board
approved, and informed consent was obtained.
A total of 178 cases were prospectively enrolled and
underwent ARA for thumb carpometacarpal (CMC)
with or without scaphotrapeziotrapezoid (STT) oste-
oarthritis (OA) between 2004 and 2011. The outcome
of 35 of these cases following ARA of pantrapezial
arthritis was previously published.9 Patients were
excluded fromﬁnal analysis if they had less than 1-year
follow-up (n ¼ 1), had prior CMC surgery (n ¼ 6), or
underwent concomitant surgical procedures (n ¼ 26)
that would likely interfere with outcome assessment.
Human acellular dermal matrix (GRAFTJACKET,
Wright Medical, Memphis, TN) was the most
commonly used interposition material. Because of
unfavorable outcomes, the senior author (T.K.C.) no
longer uses the synthetic ﬁberebased polyester scaf-
fold (Artimplant Artelon CMC-I Spacer, Small Bone
Innovations LLC, New York, NY) or the equine-
derived type I collagen scaffold (OrthADAPT Bio-
implant, Pegasus Biologics, Irvine, CA). Therefore, 6
Artelon and 13 OrthADAPT interposition cases were
excluded from the primary comparative analysis for
interposition. Nevertheless, outcomes of pain, satis-
faction, pinch strength, complications, reoperations,
and revisions for these 2 groups were reported. One
patient was lost to follow-up. This left 125 cases for
comparative analysis, 52 with human acellular dermal
matrix interposition and 73 without. There were 21
(40%) patients with pantrapezial arthritis with inter-
position and 20 (27%) without. Both the CMC and the
STT joints were resected in these 41 cases. The same
surgeon using the same criteria selected both groups.
The decision whether or not to use interposition
was based solely on changes in practice over time by
the senior author (T.K.C.). Initially, interposition wasJ Hand Surg Am. r Volused; however, over time the senior surgeon (T.K.C.)
noted no perceived beneﬁt to interposition; therefore,
later patients underwent ARA without interposition.
Demographic information is shown in Table 1.
Mean follow-up was 6.5 years (range, 4e10 y). Data
were collected before surgery, at postoperative in-
tervals of 1, 3, 6, and 12 months, and annually there-
after by an occupational hand therapist. Pinch and grip
strength were measured as previously described,9 and
pain (numerical rating scale, 0e10; 0¼ no pain, 10¼
worst imaginable pain) and satisfaction (0e5; 0 ¼ not
at all satisﬁed, 5¼ completely satisﬁed)were recorded.
Statistical analysis
Descriptive statistics were evaluated on all baseline
variables. Raw change scores of grip, pinch, and pain
outcomes were evaluated. Confounding variables at a
signiﬁcance level ofP less than .05were adjusted for in
linearmixedmodels, and an analysis of covariancewas
employed through an unstructured type of variance-
covariance matrix.
Indications and decision making
Diagnosis of CMC and STT OA was based on patient
history of pain at the base of the thumb, positive CMC
compression test, pain with palpation over the CMC
and STT joints, and positive radiographic ﬁndings of
CMC and STT OA.
Diagnostic injections were occasionally used to
help identify the pain contributions of CMC versus
STT. Diagnostic injections were performed by ﬁrst
injecting the CMC with 1 mL of 1% lidocaine under
ﬂuoroscopic control. The amount of pain relief and
strength improvement were assessed every 5 minutes
until these plateaued, usually 10 to 15minutes after the
CMC injection. The STT was then injected under
ﬂuoroscopic control. The amount of pain relief and
improvement in pinch and grip strength were again
evaluated. Patients who demonstrated substantial be-
neﬁt from both injections were considered candidates
for pantrapezial ARA.
Patients who failed conservative treatment and had
considerable disability were offered surgery. In the
absence of clinical progression, patients for as long as
tolerated continued conservative management, this
included rest, splinting, nonsteroidal anti-inﬂammatory
drugs, corticosteroid injections, and physiotherapy.
Arthroscopic staging
Accurate arthritis staging was obtained arthroscopi-
cally.4,10,11 Badia4 described stage 1 as intact CMC
articular cartilage, stage 2 as partial loss of CMC
articular cartilage, and stage 3 as widespread loss of. 40, September 2015
TABLE 1. Baseline Characteristics of Patients Who Underwent ARA of the Thumb CMC Joint
Demographic
CMC With
Interposition (n ¼ 52)
CMC Without




Male, n (%) 12 (23) 16 (22) 28 (22)
Female, n (%) 40 (77) 57 (78) 97 (78)
Age (y), mean (range) 59 (42e77) 52 (35e83) 60 (35e83)
Dominant side involved, n (%) 26 (50) 39 (53) 65 (52)
Workers’ compensation cases, n (%) 15 (29) 6 (8) 21 (17)
Pain, mean (range) 7 (4e10) 6 (1e10) 6 (1e10)
Pinch (kg), mean (range) 4.1 (0e17) 5.1 (1e12) 4.6 (0e17)
Grip (kg), mean (range) 21 (0e46) 20 (0e47) 21 (0e47)
1846 ARA FOR THUMB BASAL JOINT ARTHRITISarticular cartilage. We modiﬁed the classiﬁcation by
adding stage 4, widespread loss of articular cartilage of
both the CMC and the STT joints. Many radiographic
stage 2 patients were found to have widespread carti-
lage loss (arthroscopic stage 3) at the time of arthros-
copy and underwent ARA.12 Diagnostic arthroscopy
of the STT joint was helpful in establishing which
radiographic stage 3 cases were actually arthroscopic
stage 4.
Surgical technique
All procedures were performed with the patient under
general or regional anesthesia with or without a tour-
niquet. A tourniquet was not used if anesthetic with
epinephrine was inﬁltrated before surgery, allowing
for vasoconstriction.13,14 Patients who preferred gen-
eral anesthesia were injected with approximately 30
mL of 0.25% bupivacaine (or 1% lidocaine) with
epinephrine after onset of anesthesia.
After sterile preparation, a traction tower was used
to apply 2 to 4 kg of ﬁnger-trap traction through the
thumb. Routine arthroscopy was performed using a
1.9-, a 2.3-, or a 2.7-mm 30 arthroscope (Stryker,
Kalamazoo, MI). Most resection arthroplasties were
performed with a 2.7-mm arthroscope for a better ﬁeld
of view.
Through a small skin incision, a blunt hemostat
was used to gently dissect through the soft tissue with
a gentle circular motion while applying gentle pres-
sure until the hemostat penetrated the capsule. The
radial artery, superﬁcial branches of the radial nerve,
and extensor tendons were all at potential risk. These
structures were protected through proper technique of
blunt dissection.
Volar and dorsal portals were used. Our dorsal
portal was the same as the previously described 1-U
portal located just ulnar to the extensor pollicis brevisJ Hand Surg Am. r Voltendon.15 The volar portal was placed between the 1-R
portal described by Berger (just anterior to the abductor
pollicis longus tendon)15 and the thenar portal des-
cribed by Walsh et al.16 The STT arthroscopy was
similarly performed using portals placed approximately
1 cm proximal to the CMC portals as previously
described.9 The portalswere localizedwith hypodermic
needles that were conﬁrmed to be parallel on ﬂuoros-
copy. An accessory dorsal portal (dorsal ulnar portal)
was created when required to view the blind area over
the lateral aspect of the CMC joint or portions of the
STT joint. The dorsal ulnar portal was placed using an
inside-out technique9 by placing a blunt probe through
the volar portal across theCMCorSTT joint and exiting
the dorsum of the hand. A cannula was placed retro-
grade over the probe and inserted into the joint.
A 3.5-mm full-radius shaver was used to perform
synovectomy and clean the joint of debris for better
visualization. Loose bodies were removed. Radio-
frequency ablation (SERFAS Energy RF Ablation
System, Stryker, Kalamazoo, MI) was used to perform
thermal capsulorrhaphy with the goal of intra-articular
joint denervation of the superﬁcial radial sensory
branch, median motor branch, ulnar motor branch,
palmar cutaneous branch, and lateral antebrachial
cutaneous nerves.17e22 Using continuous outﬂow to
prevent overheating, the capsule was ablated along the
joint line circumferentially on both proximal and distal
capsular attachments. A 3.0- or 4.0-mm barrel bur
(Stryker, Kalamazoo, MI) was used to resect down to
cancellous bone (2e3 mm) on the distal surface of the
trapezium and the proximal surface of the ﬁrst meta-
carpal. Any bone spurs between theﬁrst and the second
metacarpals were removed to prevent possible
impingement. The STT resection arthroplasty was
performed similarly by removing 2 to 3 mm of bone
from the distal surface of the scaphoid and from the. 40, September 2015
ARA FOR THUMB BASAL JOINT ARTHRITIS 1847proximal surfaces of the trapezium and trapezoid. A
4.0-mm barrel bur was used preferentially in joints
large enough to accept the larger size bur. Fluoroscopy
was used to conﬁrm complete resection.
The 2 methods previously described were used to
secure the interposition material within the joint.9 For
the interposition group, when both CMC and STT
joints were resected, interposition was used in both
joints.
The resected joint was inﬁltrated with additional
anesthetic with epinephrine (if not contraindicated) to
provide hemostasis and postoperative pain control.
The total amount (including the portion used before
surgery) was calculated based on the patient’s weight
and coordinated with the anesthetist.
Postoperative care
The portals were closed with adhesive strips. A well-
padded thumb spica orthosis was applied with a
compressive elastic bandage. Patients were instructed
to come to the clinic for a postoperative pain block the
ﬁrst postoperative day if they were uncomfortable.
Preoperative, intraoperative, or postoperative blocks
were performed with 1% or 0.5% lidocaine with
epinephrine (up to a maximum single dose of 7 mg/
kg)13 or 0.25% bupivacaine with epinephrine (up to a
maximum dose of 225mg). Patients were scheduled to
see a hand therapist about 5 to 7 days after surgery for
application of a hand-based thermoplastic orthosis and
instruction for a home program of gentle range of
motion.
RESULTS
Outcomes for pain, pinch, and grip for the entire group
were 0.3 (range, 0e1), 6.4 kg (range, 5e7), and 31 kg
(range, 21e42) . Changes in outcome from preopera-
tive to ﬁnal postoperative follow-up (minimum, 1 y)
for pain, pinch, and grip scores for the with-
interposition and without-interposition groups are
shown in Table 2. Confounding variables including
hand dominance, work type, workers’ compensation,
and preoperative duration signiﬁcantly affected out-
comes and were controlled for in the analyses between
the with- versus the without-interposition groups.
Hand dominance (P¼ .03) and heavy labor work type
(P ¼ .05) positively affected grip strength. Workers’
compensation status negatively affected outcomes of
grip (P ¼ .04) and pinch strength (P ¼ .02). Greater
preoperative symptom length negatively affected grip
strength (P ¼ .02). Unadjusted (raw) pain, grip, and
pinch scores at baseline and at each postoperative in-
terval are shown in Figures 1, 2, and 3, respectively.
Raw and adjusted data (corrected for confoundingJ Hand Surg Am. r Volvariables) showed no difference when comparing with
and without interposition in pain (P¼ .86), pinch (P¼
.32), and grip (P ¼ .51). Mean ﬁnal satisfaction was
4.7 (range, 1e5) and 4.4 (range, 1e5) for the with- and
without-interposition groups, respectively. There were
4 failures in thewith- and 2 in thewithout-interposition
groups. Subgroups of with and without interposition
for CMC and pantrapezial were evaluated in the linear
mixed models for pain. No differences were found
within the CMC (P ¼ .59) or pantrapezial (P ¼ .35)
groups when comparing outcomes of pain for the with-
and without-interposition groups.
Of the 6 patients in the Artelon group, 2 had
remarkable pain and inﬂammation in the early post-
operative period requiring steroid treatment. One
patient underwent revision for persistent pain. Radio-
graphic cystic change was also seen after surgery. At a
mean ﬁnal follow-up of 5.9 years (range, 3e8 y), 5 of
the patients with surviving Artelon implants had mean
pain and satisfaction scores of 1.0 (range, 0e3) and 4.5
(range, 3e5), respectively. Average pinch strength
was 72% of the contralateral (nonsurgical) side at ﬁnal
follow-up.
Of the 13 cases receiving OrthADAPT interposi-
tion, revision surgery was required in 6 of the cases
because of persistent pain. Four patients had graft
extrusion. The surviving OrthADAPT patients had an
average ﬁnal follow-up of 8.3 years (range, 6e9 y).
Mean ﬁnal pain and satisfaction scores for this group
were 0.6 (range, 0e3) and 4.6 (range, 3e5), respec-
tively. Average pinch strength was 88% of the contra-
lateral (nonsurgical) side at ﬁnal follow-up. Cystic
changes were seen in postoperative radiographs. Four
patients had cortisone injections and 1 was given
methylprednisolone; all but 1 were given within 3
months after surgery for pain and inﬂammation.DISCUSSION
Anumber of biomaterials used for tissue augmentation
have been used for interposition after resection
arthroplasty of the thumb CMC joint. Biological
scaffolds are protein-based extracellular matrices
derived from human or animal tissue.23 In our series,
we used 2 biological scaffolds, GRAFTJACKET
(acellular dermal matrix derived from tissue bank
human skin) and OrthADAPT (derived from equine
pericardium).
One limitation of these biological scaffolds is var-
iations in biocompatibility that can cause an inﬂam-
matory response evidenced by postoperative pain,
swelling, and cystic bony changes. OrthADAPT also
demonstrated the unfavorable characteristic of not. 40, September 2015











Mean (SD) Mean (SD) P Value (95% Conﬁdence Interval)
Change in pain (pre- to
postoperative)
e6 (2.15) e5 (2.24) .86 (e1.0 to 1.3)
Change in pinch (kg) 1.5 (2.28) 1.0 (2.30) .32 (e2.6 to 2.0)
Change in grip (kg) 3 (11.31) 4 (7.42) .51 (e4.1 to 7.1)
FIGURE 1: Unadjusted raw pain scores measured at baseline and
each postoperative follow-up interval for patients who received
interposition versus those who did not.
FIGURE 2: Unadjusted raw grip scores measured at baseline and
each postoperative follow-up interval for patients who received
interposition versus those who did not.
FIGURE 3: Unadjusted raw pinch scores measured at baseline
and each postoperative follow-up interval for patients who
received interposition versus those who did not.
1848 ARA FOR THUMB BASAL JOINT ARTHRITISadhering to the host tissue, resulting in the graft being
extruded. The material in GRAFTJACKET is pro-
cessed to render it acellular, which may minimize in-
ﬂammatory response.24 Seven of the 13 patients
receivingOrthADAPT in our series didwell long term.J Hand Surg Am. r VolArtelon is a synthetic spacer made of a biode-
gradable polyurethane urea polymer.. Two of our 6
patients receiving the Artelon CMC-I spacer had a
noteworthy inﬂammatory response similar to previ-
ous reports.25e32
Controversy exists concerning interposition after
ARA for basal joint arthritis.27,33 Interposition does
offer theoretical advantages. Interposition may mini-
mize metacarpal subsidence.34,35 The senior author
(T.K.C.) has had 2 cases of spontaneous fusion of the
resected CMC space (not part of this study) without
interposition. Neither patient was happy with their
result. This complication has not occurred to our
knowledge in patients receiving interposition. We
attempted to minimize the likelihood of this compli-
cation with early range of motion and judicious use of
postoperative blocks. The senior author (T.K.C.) pre-
fers thewide-awake type blocks performed in the clinic
because patients are better able to participate in therapy
immediately after the block and patients prefer wide-
awake anesthesia to blocks by anesthesia providers.36
Blocks were repeated as necessary. The incidence
of chronic regional pain syndrome following surgical. 40, September 2015
ARA FOR THUMB BASAL JOINT ARTHRITIS 1849treatment of thumb CMC degenerative joint disease
has been reported to be as high as 19%.37 In our series,
the incidence of chronic regional pain syndrome was
zero, which may have been attributable to the use of
blocks with long-acting anesthetic. Breaking the pain
cycle may prevent the progression of chronic regional
pain syndrome.38,39
The senior author (T.K.C.) prefers partial tra-
peziectomy to complete trapeziectomy because the
former maintains thumb length and possibly better
postoperative pinch strength.2,40e48 This is supported
by 44% improved pinch strength in Cobb et al9
compared with 8%, 17%, and 33% reported by Tom-
aino et al,44 Yang and Weiland,49 and Kuhns et al,50
respectively. The patients presented in this series had
both sides of the joint resected, whereas previous au-
thors resected only one side.1e8 If removal of the tra-
pezium was responsible for the pain relief, then it
stands to reason that removal of the distal arthritic
surface (the proximal aspect of the ﬁrst metacarpal)
would provide additional pain relief. This reasoning is
in contrast to those series performing arthroscopic
debridement and synovectomywithoutARA, although
the series have been small and follow-up short.51e53
We modiﬁed the original arthroscopic stages by
adding stage 4 for STT OA or pantrapezial disease.
Pantrapezial disease was previously considered a
contraindication for ARA.2,7 Since this classiﬁcation
was proposed, ARA of the STT has been shown to be a
successful option.9 Certainly, not all arthritic STT
joints are symptomatic, and in some cases, radio-
graphic evidence of arthritis is not clinically relevant.
However, the senior author (T.K.C.) had several pa-
tients with previously asymptomatic STT OA (or with
symptomatic STT OA that was not recognized) who
underwent CMC procedures and subsequently became
sufﬁciently symptomatic to request a procedure to treat
the STT OA.
Placement of interposition material increases the
operating time and expense.54 At our institution, using
GRAFTJACKET interposition adds an additional
$2,300 per case. Such cost is not warranted without a
clear clinical beneﬁt. A theoretical risk of disease
transmission and infection also exists.
Given that there were no statistically signiﬁcant
differences in outcome when interposition is added,
our results imply that perhaps the simpler procedure,
no interposition, is the better choice. Similar ﬁnd-
ings have been found comparing simple trapeziec-
tomy with interposition or ligament reconstruction
procedures.42,55e59 Ligament reconstruction tendon
interposition has 12% more adverse effects than
simple trapeziectomy.60 Despite the evidence, 68% ofJ Hand Surg Am. r Volrespondents from an American Society for Surgery of
the Hand survey indicated that their treatment of
choice was open trapeziectomy with ligament recon-
struction tendon interposition.61
One remaining question is whether ARA is superior
to open treatment. The answer would require a pro-
spective randomized controlled trial. Arthroscopic
resection arthroplasty has the advantages of being
minimally invasive, requiring no sutures, having short
recovery time, and having low complication rates.9
The possible disadvantages of ARA include the need
for additional surgical training by surgeons and a
learning curve that can be discouraging. Although the
surgical time is prolonged during the early phase of
learning, once the skills are mastered, surgical time is
shorter than that for open procedures, as experienced
by the senior author (T.K.C.), owing to a simpler
surgical exposure and closure (no sutures used) times.
Limitations of this study include comparison groups
were not randomized and all forms of interposition
were not evaluated. In addition, the surgeon performed
noninterposition cases later in the study period, and
therefore, these cases were not subjected to the initial
learning curve. The later cases may have beneﬁtted
from greater surgical experience.
The Serfas ablater, which is currently used, is
much more aggressive (rapid and complete tissue
ablation) than the Oratek (Oratek Interventions, Inc.,
Menlo Park, CA) ablater, which was previously used.
Therefore, the completeness of the neurectomy may
have changed. The length of postoperative immobi-
lization has gradually decreased from 3 to 4 weeks in
2004 to 5 days currently, which likely affected re-
sults. The volar portal we currently use was devel-
oped over time. In the early phase of this series, we
utilized the 1-R as originally described. Finally,
diagnostic injections have not been validated.REFERENCES
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